Oncologist Dr. Chelsea Tripp discusses the background and presentation of mast cell tumors, then walks through their grading, behavior, and prognosis. You will then learn how veterinarians can screen for this disease with a new, non-invasive screening tool.
Learning Objectives
- How to speak to pet owners about the initial diagnosis and general treatment approach of mast cell tumor-specific oncology cases
- Overview of MCTs: definition, origin, and predisposition
- Spectrum, properties, and types of MCTs
- Diagnostic grading and characteristics of MCTs
- An overview of the HT Vista, a new cancer screening tool that helps veterinarians identify malignant cancer early
Part two will present a side-by-side conversation between Dr. Tripp and Clinical Pathologist Dr. Anna Meredith that will guide general practitioners on how to approach clinical cases involving MCTs, the difference between cytologic and histopathologic grading, and how to work through cases with discrepant diagnostic information.
Click here to access part two of this series and take the quiz
Click here to access the three handouts from this session
Please note that the original speaker will not be available to answer questions submitted for on-demand webinars. Our medical team will answer any questions to the best of their availability, but this may not be possible depending on the question submitted.